Resumen

BARRUE, Cristian et al. DIALCAT: Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease, Comprehensive Approach and Adherence to Treatment. Comp. y Sist. [online]. 2019, vol.23, n.2, pp.351-363.  Epub 10-Mar-2021. ISSN 2007-9737.  https://doi.org/10.13053/cys-23-2-3198.

In this article, we present the design of an mHealth system to support senior citizens with chronic diseases in managing their adherence to pharmacological treatment. The DIALCAT system consisting of a smart pill dispenser and a mobile application will be tested in a clinical study for 18 months by patients suffering diabetes with mild cognitive impairment. The clinical trial aims to study the effect of diabetes as an accelerator of cognitive impairment and Alzheimer's disease and the impact of adherence to treatment. DIALCAT is a RIS3CAT project co-funded under the European ERDF programme.

Palabras llave : eHealth; active and assisted living; diabetes; mild cognitive impairment; treatment adherence; mHealth.

        · texto en Inglés     · Inglés ( pdf )